Kymera Therapeutics Inc
(NAS:KYMR)
$
50.94
1.09 (2.19%)
Market Cap: 3.30 Bil
Enterprise Value: 2.84 Bil
PE Ratio: 0
PB Ratio: 3.69
GF Score: 50/100 Kymera Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
May 10, 2023 / 08:40PM GMT
Release Date Price:
$28.44
(+2.56%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Okay. Perfect. Welcome to the Second Day of the BofA Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here. We're thrilled to have Kymera with us. And on stage with me is Nello Mainolfi, who is the Founder, President and CEO. I got the name right, right?
Nello Mainolfi
Kymera Therapeutics, Inc. - Co-Founder, President, CEO & Director
Perfect, Geoff. Love it.
Questions & Answers
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
So maybe to kick it off, Nello give us just a high-level view here and just talk through kind of targeted protein degradation and kind of where you guys sit?
Nello Mainolfi
Kymera Therapeutics, Inc. - Co-Founder, President, CEO & Director
Excellent. So first, Geoff, thank you for inviting us. This is a great conference. We love being here, and you guys do a really great job.
So
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot